“…PTK7 overexpression has been reported in colon cancer [10,11], breast cancer [12], lung cancer [13], acute myeloid leukemia, acute lymphoid leukemia [14,15], melanoma [14,15], ovarian carcinoma, prostate cancer, lymphoma [14], glioma, and liposarcoma [16], among others. The association of aptamers with nanostructures offers huge opportunities in the research fields of diagnostics and therapeutics [17,18]. In the last decades, biocompatible nanostructures have been developed, due their particular properties as size, stability, large surface, and highly reactivity that makes them interesting for the biomedicine field.…”